Related Experiment Video
Updated: Mar 9, 2026
06:53
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020
3.3K
Tissue-Engineered Model of Human Osteolytic Bone Tumor.
Aranzazu Villasante1, Alessandro Marturano-Kruik1,2, Samuel T Robinson1
11 Department of Biomedical Engineering, Columbia University , New York, New York.
Tissue Engineering. Part C, Methods
|January 11, 2017
Summary
Researchers developed a novel bioengineered bone model to study Ewing sarcoma (ES) osteolysis. This model effectively recapitulates tumor-induced bone destruction, aiding in the development of new therapies for this pediatric cancer.
Area of Science:
- Biomedical Engineering
- Oncology
- Skeletal Biology
Background:
- Ewing sarcoma (ES) is an aggressive pediatric bone cancer known for metastasis.
- Tumor cells induce osteoclast activity, causing bone lesions, pain, and hypercalcemia.
- Current models struggle to replicate ES-induced osteolysis, hindering therapeutic development.
Purpose of the Study:
- To develop a novel, controllable bioengineered model of human bone that incorporates Ewing sarcoma.
- To enable quantitative studies of tumor-bone interactions and osteolytic processes.
- To facilitate the testing of therapeutic agents against ES-induced bone destruction.
Main Methods:
- Engineered human bone constructs with osteoblasts and osteoclasts in a 3D mineralized matrix.
- Introduction of ES cell aggregates into the engineered bone microenvironment.
- Assessment of bone density, connectivity, matrix deposition, and therapeutic agent efficacy.
Main Results:
- The engineered bone model demonstrated normal bone remodeling with osteoclast resorption and osteoblast formation.
- ES cell introduction led to decreased bone density, connectivity, and matrix deposition.
- Zoledronic acid, a known therapeutic, effectively inhibited osteoclast-mediated bone resorption in the model.
Conclusions:
- The novel bioengineered bone model accurately recapitulates Ewing sarcoma-induced osteolysis.
- This model provides a platform for studying tumor-bone interactions and evaluating therapeutic strategies.
- The model shows promise for advancing the understanding and treatment of Ewing sarcoma metastasis.
